Community Health Systems, Inc. (CYH) 10-Year Financial Performance & Capital Metrics

CYH • • Industrial / General

HealthcareHealthcare FacilitiesHospital & Acute Care FacilitiesGeneral Acute Care Hospitals

AboutCommunity Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, retail clinics, and direct-to-consumer virtual health visits. As of December 31, 2021, it owned or leased 83 hospitals, including 81 general acute care hospitals and two stand-alone rehabilitation or psychiatric hospitals with an aggregate of 13,289 licensed beds. The company was founded in 1985 and is headquartered in Franklin, Tennessee.Show more

Revenue $12.63B +1.2%
EBITDA $948M -31.4%
Net Income -$516M -288.0%
EPS (Diluted) -3.90 -282.4%
Gross Margin 41.71% +2.5%
EBITDA Margin 7.5% -32.2%
Operating Margin 4.29% -44.0%
Net Margin -4.08% -283.5%
ROE -
ROIC 3.69% -41.3%
Debt/Equity -
Interest Coverage 0.63 -45.4%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

✗Thin 5Y average net margin of 0.3%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-3.81%

5Y-0.89%

3Y0.71%

TTM0.73%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM182.66%

EPS CAGR

10Y-

5Y-

3Y-

TTM180.52%

ROCE

10Y Avg3.49%

5Y Avg7.59%

3Y Avg6.24%

Latest4.51%

Peer Comparison

General Acute Care Hospitals

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
HCAHCA Healthcare, Inc.	110.4B	483.80	21.99	8.67%	8.57%	7.13%	5.11%	81.51
UHSUniversal Health Services, Inc.	11.28B	204.19	12.14	10.82%	8.09%	18.85%	9.96%	0.73
THCTenet Healthcare Corporation	17.69B	201.32	6.16	0.57%	6.49%	15.56%	6.31%	1.68
ARDTArdent Health Partners, LLC	1.27B	8.90	5.63	10.29%	3.24%	12.57%	10.01%	1.50
AUNAAuna S.A.	138.14M	4.59	2.82	14.47%	4.33%	10.05%	100%	2.32
CYHCommunity Health Systems, Inc.	462.66M	3.34	-0.86	1.15%	2.6%		25.94%

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	19.44B	18.44B	15.35B	14.15B	13.21B	11.79B	12.37B	12.21B	12.49B	12.63B
Revenue Growth %	0.04%	-0.05%	-0.17%	-0.08%	-0.07%	-0.11%	0.05%	-0.01%	0.02%	0.01%
Cost of Goods Sold+	12.04B	11.63B	10.05B	8.74B	8.1B	7.37B	7.28B	7.3B	7.41B	7.36B
COGS % of Revenue	0.62%	0.63%	0.65%	0.62%	0.61%	0.63%	0.59%	0.6%	0.59%	0.58%
Gross Profit+	7.4B	6.8B	5.3B	5.42B	5.11B	4.42B	5.08B	4.91B	5.08B	5.27B
Gross Margin %	0.38%	0.37%	0.35%	0.38%	0.39%	0.37%	0.41%	0.4%	0.41%	0.42%
Gross Profit Growth %	0.03%	-0.08%	-0.22%	0.02%	-0.06%	-0.14%	0.15%	-0.04%	0.04%	0.04%
Operating Expenses+	6.06B	7.66B	7.18B	5.21B	4.46B	3.29B	3.68B	4.08B	4.13B	4.73B
OpEx % of Revenue	0.31%	0.42%	0.47%	0.37%	0.34%	0.28%	0.3%	0.33%	0.33%	0.37%
Selling, General & Admin	457M	450M	394M	337M	321M	327M	308M	317M	319M	299M
SG&A % of Revenue	0.02%	0.02%	0.03%	0.02%	0.02%	0.03%	0.02%	0.03%	0.03%	0.02%
Research & Development	0	0	0	0	0	0	108M	85M	80M	0
R&D % of Revenue	-	-	-	-	-	-	0.01%	0.01%	0.01%	-
Other Operating Expenses	5.6B	7.21B	6.79B	4.87B	4.14B	2.96B	3.27B	3.68B	3.73B	4.43B
Operating Income+	1.34B	-860M	-1.88B	208M	650M	1.13B	1.4B	821M	957M	542M
Operating Margin %	0.07%	-0.05%	-0.12%	0.01%	0.05%	0.1%	0.11%	0.07%	0.08%	0.04%
Operating Income Growth %	-0%	-1.64%	-1.18%	1.11%	2.13%	0.73%	0.25%	-0.41%	0.17%	-0.43%
EBITDA+	2.3B	39M	-1.2B	768M	1.14B	1.56B	1.83B	1.27B	1.38B	948M
EBITDA Margin %	0.12%	0%	-0.08%	0.05%	0.09%	0.13%	0.15%	0.1%	0.11%	0.08%
EBITDA Growth %	0.05%	-0.98%	-31.64%	1.64%	0.48%	0.37%	0.17%	-0.31%	0.09%	-0.31%
D&A (Non-Cash Add-back)	962M	899M	683M	560M	487M	435M	432M	449M	425M	406M
EBIT	1.42B	1.08B	216M	892M	902M	573M	1.28B	719M	870M	843M
Net Interest Income+	-973M	-962M	-931M	-976M	-1.04B	-1.03B	-885M	-858M	-830M	-860M
Interest Income	0	0	11M	0	0	0	0	0	2M	3M
Interest Expense	973M	962M	942M	976M	1.04B	1.03B	885M	858M	832M	863M
Other Income/Expense	-926M	-855M	-955M	-923M	0	-704M	-903M	-472M	-750M	-825M
Pretax Income+	411M	-1.72B	-2.83B	-715M	-430M	422M	499M	349M	207M	-283M
Pretax Margin %	0.02%	-0.09%	-0.18%	-0.05%	-0.03%	0.04%	0.04%	0.03%	0.02%	-0.02%
Income Tax+	116M	-104M	-449M	-11M	160M	-185M	131M	170M	191M	79M
Effective Tax Rate %	0.38%	1%	0.87%	1.1%	1.37%	1.21%	0.46%	0.13%	-0.64%	1.82%
Net Income+	158M	-1.72B	-2.46B	-788M	-590M	511M	230M	46M	-133M	-516M
Net Margin %	0.01%	-0.09%	-0.16%	-0.06%	-0.04%	0.04%	0.02%	0%	-0.01%	-0.04%
Net Income Growth %	0.72%	-11.89%	-0.43%	0.68%	0.25%	1.87%	-0.55%	-0.8%	-3.89%	-2.88%
Net Income (Continuing)	295M	-1.61B	-2.38B	-704M	-590M	607M	368M	179M	16M	-362M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	657M	667M	602M	576M	579M	571M	562M	633M	568M	597M
EPS (Diluted)+	1.37	-15.54	-22.00	-6.99	-5.19	4.38	1.76	0.35	-1.02	-3.90
EPS Growth %	0.67%	-12.34%	-0.42%	0.68%	0.26%	1.84%	-0.6%	-0.8%	-3.91%	-2.82%
EPS (Basic)	1.38	-15.55	-22.00	-6.99	-5.19	4.42	1.82	0.36	-1.02	-3.90
Diluted Shares Outstanding	115M	110.73M	111.77M	112.73M	113.74M	116.54M	130.6M	130.06M	130.45M	132.1M
Basic Shares Outstanding	114M	110.71M	111.77M	112.73M	113.74M	115.49M	126.75M	128.81M	130.39M	132.1M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	5.17B	4.67B	4.07B	3.55B	3.43B	4.51B	3.48B	3.08B	3.21B	3.3B
Cash & Short-Term Investments	184M	238M	563M	196M	216M	1.68B	507M	118M	38M	37M
Cash Only	184M	238M	563M	196M	216M	1.68B	507M	118M	38M	37M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	3.82B	3.36B	2.54B	2.51B	2.4B	2.06B	2.18B	2.14B	2.36B	2.45B
Days Sales Outstanding	71.81	66.55	60.31	64.65	66.18	63.87	64.22	63.88	69	70.69
Inventory	580M	480M	444M	402M	354M	335M	355M	353M	328M	331M
Days Inventory Outstanding	17.58	15.06	16.13	16.79	15.96	16.58	17.79	17.64	16.16	16.41
Other Current Assets	354M	382M	309M	245M	221M	202M	155M	138M	145M	197M
Total Non-Current Assets+	21.7B	17.28B	13.38B	12.31B	12.18B	11.5B	11.74B	11.59B	11.25B	10.75B
Property, Plant & Equipment	10.11B	8.15B	7.05B	6.14B	6.21B	5.96B	6.22B	6.1B	5.87B	5.4B
Fixed Asset Turnover	1.92x	2.26x	2.18x	2.31x	2.13x	1.98x	1.99x	2.00x	2.13x	2.34x
Goodwill	8.96B	6.52B	4.72B	4.56B	4.33B	4.22B	4.22B	4.17B	3.96B	3.79B
Intangible Assets	923M	674M	505M	423M	385M	305M	270M	224M	205M	172M
Long-Term Investments	479M	177M	171M	269M	283M	190M	129M	155M	170M	152M
Other Non-Current Assets	950M	1.76B	869M	851M	933M	759M	846M	890M	1.01B	1.23B
Total Assets+	26.86B	21.94B	17.45B	15.86B	15.61B	16.01B	15.22B	14.67B	14.46B	14.05B
Asset Turnover	0.72x	0.84x	0.88x	0.89x	0.85x	0.74x	0.81x	0.83x	0.86x	0.90x
Asset Growth %	-0.02%	-0.18%	-0.2%	-0.09%	-0.02%	0.03%	-0.05%	-0.04%	-0.01%	-0.03%
Total Current Liabilities+	3.07B	2.89B	2.36B	2.39B	2.28B	2.81B	2.36B	2.19B	2.14B	2.35B
Accounts Payable	1.08B	880M	801M	772M	718M	683M	725M	686M	811M	784M
Days Payables Outstanding	32.9	27.61	29.1	32.24	32.36	33.81	36.33	34.28	39.96	38.86
Short-Term Debt	229M	455M	33M	204M	156M	265M	178M	169M	145M	135M
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	935M	821M	837M	789M	814M	1.23B	806M	694M	615M	830M
Current Ratio	1.68x	1.62x	1.73x	1.48x	1.50x	1.60x	1.47x	1.41x	1.50x	1.41x
Quick Ratio	1.49x	1.45x	1.54x	1.32x	1.35x	1.48x	1.32x	1.25x	1.34x	1.27x
Cash Conversion Cycle	56.5	54.01	47.35	49.19	49.77	46.65	45.68	47.24	45.2	48.24
Total Non-Current Liabilities+	19.11B	16.77B	15.26B	14.43B	14.97B	14.24B	13.66B	13.22B	13.14B	13.03B
Long-Term Debt	16.56B	14.49B	13.59B	13.17B	13.12B	11.86B	11.72B	11.39B	11.25B	11.24B
Capital Lease Obligations	0	302M	287M	218M	752M	756M	923M	825M	777M	728M
Deferred Tax Liabilities	593M	411M	19M	26M	200M	29M	192M	354M	369M	231M
Other Non-Current Liabilities	1.7B	1.57B	1.36B	1.01B	894M	1.6B	827M	644M	739M	828M
Total Liabilities	22.18B	19.66B	17.61B	16.82B	17.25B	17.06B	16.03B	15.4B	15.28B	15.37B
Total Debt+	17.05B	15.24B	13.91B	13.6B	14.03B	12.88B	12.82B	12.39B	12.17B	12.1B
Net Debt	16.87B	15.01B	13.35B	13.4B	13.81B	11.21B	12.31B	12.27B	12.14B	12.06B
Debt / Equity	3.65x	6.68x	-	-	-	-	-	-	-	-
Debt / EBITDA	7.42x	390.87x	-	17.70x	12.34x	8.25x	6.99x	9.75x	8.81x	12.77x
Net Debt / EBITDA	7.34x	384.77x	-	17.45x	12.15x	7.18x	6.71x	9.66x	8.78x	12.73x
Interest Coverage	1.37x	-0.89x	-1.99x	0.21x	0.62x	1.09x	1.58x	0.96x	1.15x	0.63x
Total Equity+	4.68B	2.28B	-165M	-959M	-1.64B	-1.05B	-810M	-734M	-824M	-1.32B
Equity Growth %	0.01%	-0.51%	-1.07%	-4.81%	-0.71%	0.36%	0.23%	0.09%	-0.12%	-0.6%
Book Value per Share	40.66	20.61	-1.48	-8.51	-14.41	-9.04	-6.20	-5.64	-6.32	-9.97
Total Shareholders' Equity	4.02B	1.61B	-767M	-1.53B	-2.22B	-1.63B	-1.37B	-1.37B	-1.39B	-1.91B
Common Stock	1M	1M	1M	1M	1M	1M	1M	1M	1M	1M
Retained Earnings	2.13B	-299M	-2.76B	-3.54B	-4.22B	-3.71B	-3.48B	-3.43B	-3.56B	-4.08B
Treasury Stock	-7M	0	0	0	0	0	0	0	0	0
Accumulated OCI	-73M	-62M	-21M	-10M	-9M	-13M	-14M	-21M	-14M	-10M
Minority Interest	657M	667M	602M	576M	579M	571M	562M	633M	568M	597M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	921M	1.14B	773M	274M	385M	2.18B	-131M	300M	210M	480M
Operating CF Margin %	0.05%	0.06%	0.05%	0.02%	0.03%	0.18%	-0.01%	0.02%	0.02%	0.04%
Operating CF Growth %	-0.43%	0.23%	-0.32%	-0.65%	0.41%	4.66%	-1.06%	3.29%	-0.3%	1.29%
Net Income	194M	-1.71B	-2.45B	-788M	-675M	511M	230M	46M	-133M	-516M
Depreciation & Amortization	1.17B	1.1B	861M	700M	608M	558M	540M	534M	505M	486M
Stock-Based Compensation	0	0	0	0	0	0	0	0	0	0
Deferred Taxes	103M	-116M	-454M	-3M	203M	-187M	170M	165M	35M	-116M
Other Non-Cash Items	270M	3.25B	2.29B	783M	520M	-29M	305M	34M	193M	635M
Working Capital Changes	-818M	-177M	525M	-418M	-271M	1.32B	-1.38B	-479M	-390M	-9M
Change in Receivables	-219M	-96M	732M	31M	93M	309M	-136M	22M	-193M	-66M
Change in Inventory	0	0	0	0	0	0	0	0	0	0
Change in Payables	0	0	0	0	-157M	-67M	16M	-158M	-50M	137M
Cash from Investing+	-1.04B	-608M	1.07B	-273M	-3M	191M	-543M	-251M	-22M	-277M
Capital Expenditures	-1.01B	-867M	-570M	-527M	-438M	-440M	-469M	-415M	-467M	-360M
CapEx % of Revenue	0.05%	0.05%	0.04%	0.04%	0.03%	0.04%	0.04%	0.03%	0.04%	0.03%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	121M	0	0
Cash from Financing+	-206M	-1.69B	-1.52B	-368M	-362M	-909M	-495M	-438M	-268M	-204M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	106M	174M	5M	701M	-39M	-114M	-121M	-125M	-141M	-155M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-89M	1.49B	203M	-253M	-53M	1.74B	-600M	-115M	-257M	120M
FCF Margin %	-0%	0.08%	0.01%	-0.02%	-0%	0.15%	-0.05%	-0.01%	-0.02%	0.01%
FCF Growth %	-1.12%	17.73%	-0.86%	-2.25%	0.79%	33.79%	-1.35%	0.81%	-1.23%	1.47%
FCF per Share	-0.77	13.45	1.82	-2.24	-0.47	14.91	-4.59	-0.88	-1.97	0.91
FCF Conversion (FCF/Net Income)	5.83x	-0.66x	-0.31x	-0.35x	-0.65x	4.26x	-0.57x	6.52x	-1.58x	-0.93x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	3.4%	-49.47%	-232.31%	-	-	-	-	-	-	-
Return on Invested Capital (ROIC)	4.71%	-3.32%	-9.24%	1.22%	3.96%	7.57%	9.71%	5.34%	6.28%	3.69%
Gross Margin	38.06%	36.9%	34.55%	38.26%	38.7%	37.45%	41.11%	40.18%	40.69%	41.71%
Net Margin	0.81%	-9.33%	-16.02%	-5.57%	-4.47%	4.33%	1.86%	0.38%	-1.06%	-4.08%
Debt / Equity	3.65x	6.68x	-	-	-	-	-	-	-	-
Interest Coverage	1.37x	-0.89x	-1.99x	0.21x	0.62x	1.09x	1.58x	0.96x	1.15x	0.63x
FCF Conversion	5.83x	-0.66x	-0.31x	-0.35x	-0.65x	4.26x	-0.57x	6.52x	-1.58x	-0.93x
Revenue Growth	4.28%	-5.14%	-16.73%	-7.8%	-6.68%	-10.76%	4.91%	-1.27%	2.28%	1.15%

Revenue by Segment

	2012	2013	2014	2015	2016	2020	2021	2022	2023	2024
Managed Care And Other Third Party Payors	-	-	-	-	-	7.4B	7.94B	-	5.98B	6.08B
Managed Care And Other Third Party Payors Growth	-	-	-	-	-	-	7.26%	-	-	1.67%
Medicare	-	-	-	-	-	2.81B	2.65B	2.55B	2.48B	2.28B
Medicare Growth	-	-	-	-	-	-	-5.79%	-3.89%	-2.47%	-8.13%
Medicaid	-	-	-	-	-	1.58B	1.67B	1.81B	1.79B	1.87B
Medicaid Growth	-	-	-	-	-	-	5.89%	8.14%	-0.94%	4.47%
Self Pay Revenue	-	-	-	-	-	-2M	110M	83M	135M	162M
Self Pay Revenue Growth	-	-	-	-	-	-	5600.00%	-24.55%	62.65%	20.00%
Hospital Operations Reporting Unit	12.75B	12.82B	18.4B	19.23B	18.21B	-	-	-	-	-
Hospital Operations Reporting Unit Growth	-	0.50%	43.56%	4.54%	-5.32%	-	-	-	-	-
Corporate And Other	-	181.79M	240M	203M	228M	-	-	-	-	-
Corporate And Other Growth	-	-	32.02%	-15.42%	12.32%	-	-	-	-	-
Corporate And All Other Reporting Unit	277M	-	-	-	-	-	-	-	-	-
Corporate And All Other Reporting Unit Growth	-	-	-	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

Community Health Systems, Inc. (CYH) reported $12.64B in revenue for fiscal year 2024. This represents a 6% increase from $11.91B in 2011.

Community Health Systems, Inc. (CYH) grew revenue by 1.2% over the past year. Growth has been modest.

Yes, Community Health Systems, Inc. (CYH) is profitable, generating $329.0M in net income for fiscal year 2024 (-4.1% net margin).

Dividend & Returns

Community Health Systems, Inc. (CYH) generated $143.0M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

Community Health Systems, Inc. (CYH) 10-Year Financial Performance & Capital Metrics

CYH • • Industrial / General

HealthcareHealthcare FacilitiesHospital & Acute Care FacilitiesGeneral Acute Care Hospitals

Revenue $12.63B +1.2%
EBITDA $948M -31.4%
Net Income -$516M -288.0%
EPS (Diluted) -3.90 -282.4%
Gross Margin 41.71% +2.5%
EBITDA Margin 7.5% -32.2%
Operating Margin 4.29% -44.0%
Net Margin -4.08% -283.5%
ROE -
ROIC 3.69% -41.3%
Debt/Equity -
Interest Coverage 0.63 -45.4%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

✗Thin 5Y average net margin of 0.3%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-3.81%

5Y-0.89%

3Y0.71%

TTM0.73%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM182.66%

EPS CAGR

10Y-

5Y-

3Y-

TTM180.52%

ROCE

10Y Avg3.49%

5Y Avg7.59%

3Y Avg6.24%

Latest4.51%

Peer Comparison

General Acute Care Hospitals

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
HCAHCA Healthcare, Inc.	110.4B	483.80	21.99	8.67%	8.57%	7.13%	5.11%	81.51
UHSUniversal Health Services, Inc.	11.28B	204.19	12.14	10.82%	8.09%	18.85%	9.96%	0.73
THCTenet Healthcare Corporation	17.69B	201.32	6.16	0.57%	6.49%	15.56%	6.31%	1.68
ARDTArdent Health Partners, LLC	1.27B	8.90	5.63	10.29%	3.24%	12.57%	10.01%	1.50
AUNAAuna S.A.	138.14M	4.59	2.82	14.47%	4.33%	10.05%	100%	2.32
CYHCommunity Health Systems, Inc.	462.66M	3.34	-0.86	1.15%	2.6%		25.94%

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	19.44B	18.44B	15.35B	14.15B	13.21B	11.79B	12.37B	12.21B	12.49B	12.63B
Revenue Growth %	0.04%	-0.05%	-0.17%	-0.08%	-0.07%	-0.11%	0.05%	-0.01%	0.02%	0.01%
Cost of Goods Sold+	12.04B	11.63B	10.05B	8.74B	8.1B	7.37B	7.28B	7.3B	7.41B	7.36B
COGS % of Revenue	0.62%	0.63%	0.65%	0.62%	0.61%	0.63%	0.59%	0.6%	0.59%	0.58%
Gross Profit+	7.4B	6.8B	5.3B	5.42B	5.11B	4.42B	5.08B	4.91B	5.08B	5.27B
Gross Margin %	0.38%	0.37%	0.35%	0.38%	0.39%	0.37%	0.41%	0.4%	0.41%	0.42%
Gross Profit Growth %	0.03%	-0.08%	-0.22%	0.02%	-0.06%	-0.14%	0.15%	-0.04%	0.04%	0.04%
Operating Expenses+	6.06B	7.66B	7.18B	5.21B	4.46B	3.29B	3.68B	4.08B	4.13B	4.73B
OpEx % of Revenue	0.31%	0.42%	0.47%	0.37%	0.34%	0.28%	0.3%	0.33%	0.33%	0.37%
Selling, General & Admin	457M	450M	394M	337M	321M	327M	308M	317M	319M	299M
SG&A % of Revenue	0.02%	0.02%	0.03%	0.02%	0.02%	0.03%	0.02%	0.03%	0.03%	0.02%
Research & Development	0	0	0	0	0	0	108M	85M	80M	0
R&D % of Revenue	-	-	-	-	-	-	0.01%	0.01%	0.01%	-
Other Operating Expenses	5.6B	7.21B	6.79B	4.87B	4.14B	2.96B	3.27B	3.68B	3.73B	4.43B
Operating Income+	1.34B	-860M	-1.88B	208M	650M	1.13B	1.4B	821M	957M	542M
Operating Margin %	0.07%	-0.05%	-0.12%	0.01%	0.05%	0.1%	0.11%	0.07%	0.08%	0.04%
Operating Income Growth %	-0%	-1.64%	-1.18%	1.11%	2.13%	0.73%	0.25%	-0.41%	0.17%	-0.43%
EBITDA+	2.3B	39M	-1.2B	768M	1.14B	1.56B	1.83B	1.27B	1.38B	948M
EBITDA Margin %	0.12%	0%	-0.08%	0.05%	0.09%	0.13%	0.15%	0.1%	0.11%	0.08%
EBITDA Growth %	0.05%	-0.98%	-31.64%	1.64%	0.48%	0.37%	0.17%	-0.31%	0.09%	-0.31%
D&A (Non-Cash Add-back)	962M	899M	683M	560M	487M	435M	432M	449M	425M	406M
EBIT	1.42B	1.08B	216M	892M	902M	573M	1.28B	719M	870M	843M
Net Interest Income+	-973M	-962M	-931M	-976M	-1.04B	-1.03B	-885M	-858M	-830M	-860M
Interest Income	0	0	11M	0	0	0	0	0	2M	3M
Interest Expense	973M	962M	942M	976M	1.04B	1.03B	885M	858M	832M	863M
Other Income/Expense	-926M	-855M	-955M	-923M	0	-704M	-903M	-472M	-750M	-825M
Pretax Income+	411M	-1.72B	-2.83B	-715M	-430M	422M	499M	349M	207M	-283M
Pretax Margin %	0.02%	-0.09%	-0.18%	-0.05%	-0.03%	0.04%	0.04%	0.03%	0.02%	-0.02%
Income Tax+	116M	-104M	-449M	-11M	160M	-185M	131M	170M	191M	79M
Effective Tax Rate %	0.38%	1%	0.87%	1.1%	1.37%	1.21%	0.46%	0.13%	-0.64%	1.82%
Net Income+	158M	-1.72B	-2.46B	-788M	-590M	511M	230M	46M	-133M	-516M
Net Margin %	0.01%	-0.09%	-0.16%	-0.06%	-0.04%	0.04%	0.02%	0%	-0.01%	-0.04%
Net Income Growth %	0.72%	-11.89%	-0.43%	0.68%	0.25%	1.87%	-0.55%	-0.8%	-3.89%	-2.88%
Net Income (Continuing)	295M	-1.61B	-2.38B	-704M	-590M	607M	368M	179M	16M	-362M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	657M	667M	602M	576M	579M	571M	562M	633M	568M	597M
EPS (Diluted)+	1.37	-15.54	-22.00	-6.99	-5.19	4.38	1.76	0.35	-1.02	-3.90
EPS Growth %	0.67%	-12.34%	-0.42%	0.68%	0.26%	1.84%	-0.6%	-0.8%	-3.91%	-2.82%
EPS (Basic)	1.38	-15.55	-22.00	-6.99	-5.19	4.42	1.82	0.36	-1.02	-3.90
Diluted Shares Outstanding	115M	110.73M	111.77M	112.73M	113.74M	116.54M	130.6M	130.06M	130.45M	132.1M
Basic Shares Outstanding	114M	110.71M	111.77M	112.73M	113.74M	115.49M	126.75M	128.81M	130.39M	132.1M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	5.17B	4.67B	4.07B	3.55B	3.43B	4.51B	3.48B	3.08B	3.21B	3.3B
Cash & Short-Term Investments	184M	238M	563M	196M	216M	1.68B	507M	118M	38M	37M
Cash Only	184M	238M	563M	196M	216M	1.68B	507M	118M	38M	37M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	3.82B	3.36B	2.54B	2.51B	2.4B	2.06B	2.18B	2.14B	2.36B	2.45B
Days Sales Outstanding	71.81	66.55	60.31	64.65	66.18	63.87	64.22	63.88	69	70.69
Inventory	580M	480M	444M	402M	354M	335M	355M	353M	328M	331M
Days Inventory Outstanding	17.58	15.06	16.13	16.79	15.96	16.58	17.79	17.64	16.16	16.41
Other Current Assets	354M	382M	309M	245M	221M	202M	155M	138M	145M	197M
Total Non-Current Assets+	21.7B	17.28B	13.38B	12.31B	12.18B	11.5B	11.74B	11.59B	11.25B	10.75B
Property, Plant & Equipment	10.11B	8.15B	7.05B	6.14B	6.21B	5.96B	6.22B	6.1B	5.87B	5.4B
Fixed Asset Turnover	1.92x	2.26x	2.18x	2.31x	2.13x	1.98x	1.99x	2.00x	2.13x	2.34x
Goodwill	8.96B	6.52B	4.72B	4.56B	4.33B	4.22B	4.22B	4.17B	3.96B	3.79B
Intangible Assets	923M	674M	505M	423M	385M	305M	270M	224M	205M	172M
Long-Term Investments	479M	177M	171M	269M	283M	190M	129M	155M	170M	152M
Other Non-Current Assets	950M	1.76B	869M	851M	933M	759M	846M	890M	1.01B	1.23B
Total Assets+	26.86B	21.94B	17.45B	15.86B	15.61B	16.01B	15.22B	14.67B	14.46B	14.05B
Asset Turnover	0.72x	0.84x	0.88x	0.89x	0.85x	0.74x	0.81x	0.83x	0.86x	0.90x
Asset Growth %	-0.02%	-0.18%	-0.2%	-0.09%	-0.02%	0.03%	-0.05%	-0.04%	-0.01%	-0.03%
Total Current Liabilities+	3.07B	2.89B	2.36B	2.39B	2.28B	2.81B	2.36B	2.19B	2.14B	2.35B
Accounts Payable	1.08B	880M	801M	772M	718M	683M	725M	686M	811M	784M
Days Payables Outstanding	32.9	27.61	29.1	32.24	32.36	33.81	36.33	34.28	39.96	38.86
Short-Term Debt	229M	455M	33M	204M	156M	265M	178M	169M	145M	135M
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	935M	821M	837M	789M	814M	1.23B	806M	694M	615M	830M
Current Ratio	1.68x	1.62x	1.73x	1.48x	1.50x	1.60x	1.47x	1.41x	1.50x	1.41x
Quick Ratio	1.49x	1.45x	1.54x	1.32x	1.35x	1.48x	1.32x	1.25x	1.34x	1.27x
Cash Conversion Cycle	56.5	54.01	47.35	49.19	49.77	46.65	45.68	47.24	45.2	48.24
Total Non-Current Liabilities+	19.11B	16.77B	15.26B	14.43B	14.97B	14.24B	13.66B	13.22B	13.14B	13.03B
Long-Term Debt	16.56B	14.49B	13.59B	13.17B	13.12B	11.86B	11.72B	11.39B	11.25B	11.24B
Capital Lease Obligations	0	302M	287M	218M	752M	756M	923M	825M	777M	728M
Deferred Tax Liabilities	593M	411M	19M	26M	200M	29M	192M	354M	369M	231M
Other Non-Current Liabilities	1.7B	1.57B	1.36B	1.01B	894M	1.6B	827M	644M	739M	828M
Total Liabilities	22.18B	19.66B	17.61B	16.82B	17.25B	17.06B	16.03B	15.4B	15.28B	15.37B
Total Debt+	17.05B	15.24B	13.91B	13.6B	14.03B	12.88B	12.82B	12.39B	12.17B	12.1B
Net Debt	16.87B	15.01B	13.35B	13.4B	13.81B	11.21B	12.31B	12.27B	12.14B	12.06B
Debt / Equity	3.65x	6.68x	-	-	-	-	-	-	-	-
Debt / EBITDA	7.42x	390.87x	-	17.70x	12.34x	8.25x	6.99x	9.75x	8.81x	12.77x
Net Debt / EBITDA	7.34x	384.77x	-	17.45x	12.15x	7.18x	6.71x	9.66x	8.78x	12.73x
Interest Coverage	1.37x	-0.89x	-1.99x	0.21x	0.62x	1.09x	1.58x	0.96x	1.15x	0.63x
Total Equity+	4.68B	2.28B	-165M	-959M	-1.64B	-1.05B	-810M	-734M	-824M	-1.32B
Equity Growth %	0.01%	-0.51%	-1.07%	-4.81%	-0.71%	0.36%	0.23%	0.09%	-0.12%	-0.6%
Book Value per Share	40.66	20.61	-1.48	-8.51	-14.41	-9.04	-6.20	-5.64	-6.32	-9.97
Total Shareholders' Equity	4.02B	1.61B	-767M	-1.53B	-2.22B	-1.63B	-1.37B	-1.37B	-1.39B	-1.91B
Common Stock	1M	1M	1M	1M	1M	1M	1M	1M	1M	1M
Retained Earnings	2.13B	-299M	-2.76B	-3.54B	-4.22B	-3.71B	-3.48B	-3.43B	-3.56B	-4.08B
Treasury Stock	-7M	0	0	0	0	0	0	0	0	0
Accumulated OCI	-73M	-62M	-21M	-10M	-9M	-13M	-14M	-21M	-14M	-10M
Minority Interest	657M	667M	602M	576M	579M	571M	562M	633M	568M	597M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	921M	1.14B	773M	274M	385M	2.18B	-131M	300M	210M	480M
Operating CF Margin %	0.05%	0.06%	0.05%	0.02%	0.03%	0.18%	-0.01%	0.02%	0.02%	0.04%
Operating CF Growth %	-0.43%	0.23%	-0.32%	-0.65%	0.41%	4.66%	-1.06%	3.29%	-0.3%	1.29%
Net Income	194M	-1.71B	-2.45B	-788M	-675M	511M	230M	46M	-133M	-516M
Depreciation & Amortization	1.17B	1.1B	861M	700M	608M	558M	540M	534M	505M	486M
Stock-Based Compensation	0	0	0	0	0	0	0	0	0	0
Deferred Taxes	103M	-116M	-454M	-3M	203M	-187M	170M	165M	35M	-116M
Other Non-Cash Items	270M	3.25B	2.29B	783M	520M	-29M	305M	34M	193M	635M
Working Capital Changes	-818M	-177M	525M	-418M	-271M	1.32B	-1.38B	-479M	-390M	-9M
Change in Receivables	-219M	-96M	732M	31M	93M	309M	-136M	22M	-193M	-66M
Change in Inventory	0	0	0	0	0	0	0	0	0	0
Change in Payables	0	0	0	0	-157M	-67M	16M	-158M	-50M	137M
Cash from Investing+	-1.04B	-608M	1.07B	-273M	-3M	191M	-543M	-251M	-22M	-277M
Capital Expenditures	-1.01B	-867M	-570M	-527M	-438M	-440M	-469M	-415M	-467M	-360M
CapEx % of Revenue	0.05%	0.05%	0.04%	0.04%	0.03%	0.04%	0.04%	0.03%	0.04%	0.03%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	121M	0	0
Cash from Financing+	-206M	-1.69B	-1.52B	-368M	-362M	-909M	-495M	-438M	-268M	-204M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	106M	174M	5M	701M	-39M	-114M	-121M	-125M	-141M	-155M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-89M	1.49B	203M	-253M	-53M	1.74B	-600M	-115M	-257M	120M
FCF Margin %	-0%	0.08%	0.01%	-0.02%	-0%	0.15%	-0.05%	-0.01%	-0.02%	0.01%
FCF Growth %	-1.12%	17.73%	-0.86%	-2.25%	0.79%	33.79%	-1.35%	0.81%	-1.23%	1.47%
FCF per Share	-0.77	13.45	1.82	-2.24	-0.47	14.91	-4.59	-0.88	-1.97	0.91
FCF Conversion (FCF/Net Income)	5.83x	-0.66x	-0.31x	-0.35x	-0.65x	4.26x	-0.57x	6.52x	-1.58x	-0.93x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	3.4%	-49.47%	-232.31%	-	-	-	-	-	-	-
Return on Invested Capital (ROIC)	4.71%	-3.32%	-9.24%	1.22%	3.96%	7.57%	9.71%	5.34%	6.28%	3.69%
Gross Margin	38.06%	36.9%	34.55%	38.26%	38.7%	37.45%	41.11%	40.18%	40.69%	41.71%
Net Margin	0.81%	-9.33%	-16.02%	-5.57%	-4.47%	4.33%	1.86%	0.38%	-1.06%	-4.08%
Debt / Equity	3.65x	6.68x	-	-	-	-	-	-	-	-
Interest Coverage	1.37x	-0.89x	-1.99x	0.21x	0.62x	1.09x	1.58x	0.96x	1.15x	0.63x
FCF Conversion	5.83x	-0.66x	-0.31x	-0.35x	-0.65x	4.26x	-0.57x	6.52x	-1.58x	-0.93x
Revenue Growth	4.28%	-5.14%	-16.73%	-7.8%	-6.68%	-10.76%	4.91%	-1.27%	2.28%	1.15%

Revenue by Segment

	2012	2013	2014	2015	2016	2020	2021	2022	2023	2024
Managed Care And Other Third Party Payors	-	-	-	-	-	7.4B	7.94B	-	5.98B	6.08B
Managed Care And Other Third Party Payors Growth	-	-	-	-	-	-	7.26%	-	-	1.67%
Medicare	-	-	-	-	-	2.81B	2.65B	2.55B	2.48B	2.28B
Medicare Growth	-	-	-	-	-	-	-5.79%	-3.89%	-2.47%	-8.13%
Medicaid	-	-	-	-	-	1.58B	1.67B	1.81B	1.79B	1.87B
Medicaid Growth	-	-	-	-	-	-	5.89%	8.14%	-0.94%	4.47%
Self Pay Revenue	-	-	-	-	-	-2M	110M	83M	135M	162M
Self Pay Revenue Growth	-	-	-	-	-	-	5600.00%	-24.55%	62.65%	20.00%
Hospital Operations Reporting Unit	12.75B	12.82B	18.4B	19.23B	18.21B	-	-	-	-	-
Hospital Operations Reporting Unit Growth	-	0.50%	43.56%	4.54%	-5.32%	-	-	-	-	-
Corporate And Other	-	181.79M	240M	203M	228M	-	-	-	-	-
Corporate And Other Growth	-	-	32.02%	-15.42%	12.32%	-	-	-	-	-
Corporate And All Other Reporting Unit	277M	-	-	-	-	-	-	-	-	-
Corporate And All Other Reporting Unit Growth	-	-	-	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

Community Health Systems, Inc. (CYH) reported $12.64B in revenue for fiscal year 2024. This represents a 6% increase from $11.91B in 2011.

Community Health Systems, Inc. (CYH) grew revenue by 1.2% over the past year. Growth has been modest.

Yes, Community Health Systems, Inc. (CYH) is profitable, generating $329.0M in net income for fiscal year 2024 (-4.1% net margin).

Dividend & Returns

Community Health Systems, Inc. (CYH) generated $143.0M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.